Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Operating Leases: 2023-2024

Historic Operating Leases for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $218,000.

  • Zenas BioPharma's Operating Leases was N/A to $180,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $180,000, marking a year-over-year change of. This contributed to the annual value of $218,000 for FY2024, which is 15.18% down from last year.
  • Zenas BioPharma's Operating Leases amounted to $218,000 in FY2024, which was down 15.18% from $257,000 recorded in FY2023.
  • Zenas BioPharma's 5-year Operating Leases high stood at $257,000 for FY2023, and its period low was $218,000 during FY2024.
  • For the 2-year period, Zenas BioPharma's Operating Leases averaged around $237,500, with its median value being $237,500 (2023).
  • Data for Zenas BioPharma's Operating Leases shows a maximum YoY decreased of 15.18% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zenas BioPharma's Operating Leases stood at $257,000 in 2023, then decreased by 15.18% to $218,000 in 2024.